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Abstract 22 
  The WHO 2016 report indicates that worldwide obesity is rising, with 23 
over 600 million people in the obese range (BMI>30). The recommended daily 24 
calorie intake for adults is 2000 kcal and 2500 kcal for women and men 25 
respectively. The average American consumes 3770 kcal/ day and the average 26 
person in the UK consumes 3400 kcal/ day. With such increased caloric intake, 27 
there is an increased load on metabolic pathways, in particular glucose 28 
metabolism. Such metabolism requires micronutrients as enzyme co-factors. The 29 
recommended daily allowance (RDA) for thiamine is 1.3mg/day and 0.5mg 30 
thiamine is required to process 1000 kilocalories (kcal). Therefore, despite the 31 
appearance of being overfed, there is now increasing evidence that the obese 32 
population may nutritionally depleted of essential micronutrients. Thiamine 33 
deficiency has been reported to be in the region of 16 – 47% among patients 34 
undergoing bariatric surgery for obesity. Thiamine, in turn, requires magnesium 35 
to be in its active form, thiamine diphosphate (TDP). TDP also requires 36 
magnesium to achieve activation of TDP dependent enzymes, including 37 
transketolase (TK), pyruvate dehydrogenase (PDH) and alpha-keto glutaric acid 38 
dehydrogenase (AKGDH), during metabolism of glucose. Thiamine and 39 
magnesium therefore play a critical role in glucose metabolism and their 40 
deficiency may result in the accumulation of anaerobic metabolites including 41 
lactate due to a mismatch between caloric burden and function of thiamine 42 
dependent enzymes. It may therefore be postulated that thiamine and 43 
magnesium deficiency are under-recognized in obesity and may be important in 44 
the progress of obesity and obesity related chronic disease states. The aim of the 45 
present systematic review was to examine the role of thiamine dependent 46 
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enzymes in obesity and obesity related chronic disease states.  47 
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Introduction 66 
In 2008 it was estimated that 1·46 billion adults worldwide were 67 
overweight and 502 million people were estimated to be in the obese range (1). 68 
The WHO 2016 report indicates that these figures have significantly increased, 69 
estimating more than 1.9 billion adults are overweight (BMI>25), of which over 70 
600 million of these are obese (BMI>30) (2). Alarmingly, childhood obesity levels 71 
have risen in tandem with adult obesity. WHO statistics reveal that 41 million 72 
children under the age of 5 were overweight or obese in 2014 (2). 73 
Increasing obesity is primarily due to increased consumption of calories 74 
(3, 4). The recommended daily calorie intake is 2000 kcal and 2500 kcal for adult 75 
women and men respectively (4). The average American consumes 3770 kcal/ 76 
day and the average person in the UK consumes 3400 kcal/ day (1). These 77 
figures are steadily rising due to the ready availability of ‘high sugar, low 78 
nutrient’ foods, that characterize the North American and Western European diet 79 
(5). Chronic calorie excess is now endemic in Western society, with a reported 80 
35 - 40% North Americans having BMI’s in the obese range (BMI>30) (4). Indeed, 81 
obesity has now overtaken smoking to become the number one cause of 82 
preventable death in some of the Western nations (6-8).  83 
The burden of obesity worldwide now poses a significant risk to 84 
population health and some experts warn that the obesity pandemic threatens to 85 
reverse the gains achieved in risk reduction for cardiovascular and cancer deaths 86 
over the past three decades (1, 4, 9). The caloric burden on individuals in 87 
Western societies has increased as a consequence of changing diet. This has 88 
imposed a sugar rich nutritional intake on a metabolism evolved in a sugar poor 89 
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evolutionary environment (10-13). Total health-care costs attributable to 90 
obesity and overweight are projected to double every decade to account for 16–91 
18% of total US health-care expenditure by 2030 (1).  92 
Despite the appearance of being overfed, there is now increasing evidence 93 
that this population is nutritionally depleted of essential micronutrients and 94 
vitamins (14-16). In 2012 the National Research Council reported that  >80% 95 
Americans consumed a diet, which was deficient for vitamins and minerals (15, 96 
17). The NHANES 3 study reported that multi-nutrient deficiencies were more 97 
prevalent in those with a BMI in the obese range than in the normal population 98 
(18-21). In the present review we will examine the role of thiamine, an essential 99 
component in the metabolism of glucose, in patients with obesity. 100 
 101 
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Search strategy and methodology 111 
This review set out to examine, in a systematic manner, studies that 112 
report association between obesity, thiamine and /or magnesium deficiency, and 113 
proposes the novel concepts that a combined deficiency of thiamine and 114 
magnesium may result in loss of responsiveness to insulin by the pyruvate 115 
dehydrogenase enzyme complex, and that this may serve as the metabolic 116 
fulcrum underpinning pseudohypoxic disease processes. 117 
A PubMed literature search was performed in accordance with the 118 
PRISMA statement. The search focused on obesity and bariatric surgery in 119 
relation to thiamine or magnesium deficiency. Search keywords included: 120 
“bariatric surgery” OR “obesity” OR “non-insulin dependent diabetes” OR “type 2 121 
diabetes” OR “metabolic syndrome” AND “thiamine” OR “thiamine deficiency”, 122 
AND “magnesium” OR “magnesium deficiency”. Inclusion criteria for each article 123 
were: an experimental or observational measurement of thiamine and or 124 
magnesium in relation to obesity or bariatric surgery at any age in human 125 
participants, between 1946 and October 2017 (see appendix 1). Additional 126 
papers, which were found through bibliographic reviews, were also included 127 
(see appendix 2).  128 
Databases including MEDLINE, science direct, Scopus, Google scholar and 129 
Cochrane were searched from inception to October 2017.  Observational studies 130 
were reviewed using the MOOSE checklist for guidance. 131 
Citations from searches were imported into referencing software Endnote 132 
X7, whereupon title and abstract were screened for inclusion criteria (22). Case 133 
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studies, case reports and animal studies were excluded. Supporting evidence was 134 
provided by in vitro and ex vivo cellular studies of adipocytes in eligible human 135 
studies. There were no language or date restrictions. A copy of articles that met 136 
the inclusion criteria was obtained for full-text review. No article was 137 
unavailable.  138 
 139 
Thiamine metabolism 140 
Thiamine (Vitamin B1) is a water-soluble vitamin, that is required for the 141 
metabolism of glucose (23). Thiamine is commonly found in meat (particularly 142 
pork), eggs, fish and whole grains (23). Indeed, legislation in the United States 143 
and Australia requires that certain staple foods, such as bread, be fortified with 144 
thiamine (24). Many ‘breakfast cereal’ type foods are also supplemented (25, 26), 145 
and  ‘over the counter’ thiamine containing multivitamins are now widely 146 
available (27). 147 
Under normal physiological and nutritional conditions, the average adult 148 
human has approximately a 3-week reserve of thiamine in the liver.  It is 149 
postulated that these reserves become rapidly depleted in disease, surgery or 150 
times of sustained physiological stress (28-33). 151 
The measurement of thiamine in red blood cells is known to reflect 152 
nutritional status, and is not perturbed by the systemic inflammatory response 153 
(34-36). Therefore, it is of interest that thiamine deficiency has been reported to 154 
be in the region of 16 – 29% among patients undergoing bariatric surgery for 155 
obesity (37-39), and this deficiency was reported to be even higher (31 – 47%) 156 
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among some ethnic groups (15, 38). These findings are endorsed by a cross-157 
sectional study of thiamine consumption in a population of 1,100 Mexican-158 
American children, generated from NHANES data, which reported that thiamine 159 
consumption may be inversely associated with obesity in that group (40). 160 
Thiamine deficiency has also been reported to be present in up to 75% of 161 
both type 1 and type 2 diabetics (41), and urinary excretion of thiamine has been 162 
reported to be 24 times higher in Type 1 diabetes and 16 times higher in type 2 163 
diabetes as compared to normal controls (41). Hence, thiamine deficiency has 164 
been proposed as a mediator of insulin resistance and loss of oxidative resilience 165 
in diabetes (42).  166 
A pilot cross-over prospective randomized controlled trail (PRCT) (n= 12) 167 
reported that thiamine supplementation (100mg taken three times per day for 6 168 
weeks) resulted in significant decrease in 2-h plasma glucose relative to baseline 169 
(8.78 +/- 2.20 vs. 9.89 +/- 2.50 mmol/l, p = 0.004) (43). It has also been reported 170 
that thiamine supplementation may exert a nephro-protective effect in NIDDM 171 
patients with evidence of early stage diabetic nephropathy and pilot studies have 172 
yielded encouraging results (44, 45).   173 
Given that the recommended daily allowance for thiamine is 1.3mg/day, 174 
and that the average daily intake of thiamine from food for American adults is 175 
1.87mg and 1.39mg in men and women respectively (46), and from the 176 
combination of food and supplements is 4.90 in both men and women (47), it is 177 
perhaps surprising that there are reported deficiencies in the obese. However, 178 
the current recommended daily allowance for thiamine is based on studies 179 
undertaken in the 1930's on healthy volunteers (48). At this time daily calorie 180 
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intakes were far lower than today. Nevertheless, from this work it may be 181 
assumed that 0.5mg thiamine is required to process 1000kcal (kcal) (18, 23, 49). 182 
On the basis of a 4000 kcal/day intake, it might be expected that an appropriate 183 
RDA would be 2.0 mg /day. However, this would assume a linear relationship 184 
between calories consumed and thiamine requirement.   185 
  186 
Pre-bariatric surgery related evidence of thiamine deficiency 187 
 A comprehensive literature search reveals 53 case reports describing the 188 
development of Wernicke’s encephalopathy in patients during the post-189 
operative period following bariatric surgery. It is therefore surprising that there 190 
are only five studies published that sought to quantify the extent of pre-191 
operative thiamine deficiency in patients undergoing bariatric surgery (37-39, 192 
50, 51). Nath et al report a 16.5% prevalence of preoperative thiamine deficiency 193 
(39). Carrodeguas et al and Flancbaum report a prevalence of 15.5% and 29% 194 
low thiamine concentrations in obese patients prior to bariatric surgery 195 
respectively (37, 38). Peterson et al also report significant thiamine deficiency in 196 
patients prior to bariatric surgery, and note a significant racial disparity 197 
(patients of Hispanic origin = 33%), which is in keeping with the ethnic 198 
preponderance reported by Flancbaum et al (38, 50). Aron-Wisnewsky et al 199 
report a preoperative prevalence of thiamine deficiency among 23% of the 22 200 
women who underwent weight reduction surgery at their center (51). 201 
However, it is worth noting that both Aron-Wisnewsky et al and  202 
Flancbaum et al reported their results based on measurement of serum thiamine 203 
concentrations (38). The National Institute of Health guidance on the 204 
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measurement of thiamine status states that 'Levels of thiamine in the plasma are 205 
not reliable indicators of thiamine status' (52).  Erythrocyte transketolase 206 
activity (ETKA) ratios, or erythrocyte (red cell) thiamine diphosphate (TDP) 207 
concentration measured in whole blood, are considered the gold standards for 208 
thiamine status, as they are based on the intracellular concentration of the 209 
vitamin (52).  210 
Red cell TDP measurement from whole blood is recognized as a reliable 211 
measure of thiamine status, which some regard as equivalent or superior to 212 
ETKA measurement (53, 54). Red cell TDP assay may have an advantage over the 213 
ETKA assay for detecting tissue thiamine accumulation, however ETKA has the 214 
benefit of being a functional marker of thiamine status (55). Red cell TDP is more 215 
commonly measuremed, as ETKA is a more time consuming assay to perform 216 
(56). In particular, processing of blood samples for ETKA assay is time and 217 
temperature dependent, as processing or storage delay renders the sample 218 
prone to variable kinetics (57). Talwar and colleagues have reported that direct 219 
measurement of whole-blood TDP mass is most accurately expressed when 220 
placed in the context of haemoglobin mass (expressed in units: nanogram of TDP 221 
per gram of haemoglobin i.e. ng/g Hb) (54) as this corrects for unavoidable 222 
pipetting related volume sampling error.  223 
Red cell TDP measurement was used in two of the bariatric surgery 224 
studies described above (37, 39). It is interesting to note however that the 225 
normal ranges and deficiency thresholds listed for each study vary significantly 226 
between institutions, and that certain patients deemed to be deficient in one 227 
study would not have met the criteria for biochemical deficiency in another (see 228 
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appendix 3) (37, 38, 58). Indeed, one of the studies provided no specific values of 229 
whole blood thiamine concentrations, however this study does correlate clinical 230 
criteria of symptoms related to thiamine deficiency with biochemically proven 231 
deficiency measured in whole blood (i.e. red cell thiamine diphosphate) (38).  232 
Overall, there is some evidence of an association between thiamine 233 
deficiency and obesity, however given the scale of the problem there is a relative 234 
paucity of robust data available describing thiamine status in obese patients. 235 
This is surprising for a patient group who are known to be at risk of manifesting 236 
clinical signs of thiamine deficiency in the postoperative period after undergoing 237 
bariatric surgery (51, 59-63).  238 
 239 
The role of thiamine in glucose metabolism 240 
  In the obese patient, most calories are in the form of glucose and there are 241 
several key enzymes that require thiamine as a co-factor (64-66). Briefly, a 242 
glucose load causes the pancreas to secrete insulin (67). Insulin causes the 243 
expression of GLUT receptor transporters on the membrane of non-endothelial 244 
and non-mesenchymal cells (68, 69). Glucose is taken into the cell where it is 245 
metabolized to pyruvate via the glycolytic pathway (70, 71). Under ideal 246 
conditions pyruvate enters the mitochondrion and is converted to Acetyl-CoA 247 
through the action of pyruvate dehydrogenase (PDH) (64). Acetyl-CoA combines 248 
with oxaloacetate to form citrate and thence through the action of alpha 249 
ketoglutaric acid dehydrogenase (KGDH), generates ATP via the (Kreb’s) 250 
Tricarboxylic Acid (TCA) cycle (64). This may be considered to be the optimal 251 
metabolism of glucose i.e. ‘a clean burn’. 252 
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  Thiamine in the form of thiamine diphosphate (TDP) (also known as 253 
thiamine pyrophosphate) is required as a co-factor for pyruvate dehydrogenase 254 
(PDH) and alpha ketoglutaric acid dehydrogenase (KGDH), both key enzymes for 255 
the TCA cycle. Therefore, thiamine deficiency compromises these enzymes and 256 
results in an altered metabolism of glucose.  257 
 258 
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259 
  260 
Figure 1(a) Normal glucose metabolism in the presence of normoxia and 261 
adequate micronutrient concentration i.e. ‘a clean burn’ 262 
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 Thiamine deficiency compromises PDH activity, hence pyruvate is unable to 263 
gain access into the mitochondrion for conversion to acetyl-CoA and thereby 264 
onto the TCA cycle (64). The resulting ‘glut’ of pyruvate in the cytosol triggers 265 
up-regulation of lactate dehydrogenase (LDH) activity (72). LDH mediates the 266 
increased production of lactate, which accumulates in the cytosol (73). This may 267 
be considered to be the suboptimal metabolism of glucose i.e. ‘a dirty burn’. 268 
  269 
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 270 
Figure 1(b) Altered glucose metabolism due to compromised TDP dependent 271 
enzyme function i.e. ‘a dirty burn’ 272 
 273 
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Pentose Phosphate Pathway, lactic acid and fatty acid synthesis 274 
 The Pentose Phosphate Pathway (PPP) is a cytoplasmic pathway composed 275 
of two arms: one irreversible and the other reversible. The irreversible arm is 276 
oxidative and generates NADPH that plays a vital role in maintaining the cellular 277 
redox balance. NADPH provides essential redox potential for synthetic pathways 278 
e.g. fatty acid synthesis. The reversible arm is non-oxidative and links the 279 
products of the irreversible arm back into the glycolytic pathway (74). 280 
 The ‘glut’ of pyruvate generated by suboptimal PDH activity may cause 281 
diversion of glucose metabolism into the oxidative arm of the PPP (74, 75). This 282 
increased flux through the oxidative arm of the PPP may then generate a net 283 
excess of NADPH (75, 76). Interestingly, the conversion of pyruvate to lactate by 284 
LDH also requires the conversion of NADPH to NADP+, and excess of NADPH may 285 
therefore drive the reaction towards increased production of lactate (72, 77). 286 
 Furthermore, fatty acid synthesis requires the conversion of NADPH to NADP+; 287 
hence excess NADPH may also facilitate increased fatty acid synthesis (76, 78). 288 
The significance of a sustained elevation of serum lactate concentration is well 289 
recognized as a marker of compromised oxidative resilience in the acute setting, 290 
and as such has an established prognostic value. The threshold of normality for 291 
blood lactate concentration is < 2.0 mmol/L. A recent publication by Varis et al 292 
highlights the finding that a concentration >2 mmol/L among patients admitted 293 
to an Intensive Care Unit (ICU) is consistently associated with a higher 90-day 294 
mortality than a lactate concentration ≤2 mmol/L (43% vs. 22%) (79). 295 
Furthermore, patients who continue to manifest hyperlactatemia (>2 mmol/L) at 296 
≥72 hours post admission to ICU are reported to have more than double the 90-297 
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day mortality when compared with those patients whose lactate concentration 298 
has resolved to ≤2.0 mmol/L at the same time point (52% vs. 24%) (79). Chronic 299 
low-grade elevation of serum lactate concentrations at the upper limit of normal 300 
may therefore indicate a reduced oxidative reserve and an increased 301 
vulnerability to systemic insult and oxidative stress. Pepper et al conducted a 302 
systematic review and meta analysis of the correlation between mortality and 303 
elevated BMI among patients admitted to ICU (80). This highlighted the counter-304 
intuitive perspective of the ‘obesity survival paradox’ by revealing that a BMI in 305 
the over-weight and obese ranges (BMI= 25 – 30 and 30 - 35 kg/m2) may be a 306 
protective factor for patients admitted to ICU with a diagnosis of sepsis, while a 307 
BMI in the morbidly obese range (BMI > 35 kg/m2) does not reduce mortality 308 
(80). However, this meta-analysis was contradicted by a more recent and larger 309 
meta-analysis conducted by Wang et al, which found that overweight, but not 310 
obesity or morbid obesity, was associated with lower mortality in patients 311 
admitted to ICU with a diagnosis of sepsis (80). 312 
 The implications of the thiamine deficiency state also extend directly to the 313 
non-oxidative reversible arm of the PPP. Transketolase (TK) is also a TDP 314 
dependent enzyme, which catalyzes the reversible arm of the PPP (81). Indeed, it 315 
is this enzyme which has shown promise for combined co-factor 316 
supplementation with magnesium (82). Compromised TK activity results in the 317 
accumulation of a precursor to nucleotide synthesis, ribose-5- phosphate (83). 318 
Indeed, accumulation of ribose-5-phosphate may serve to drive the process of 319 
cell division.  320 
 321 
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Genetic variation in thaimine tansporters and thiamine dependent 322 
enzymes 323 
 SLC19-A2 and SLC19-A3 code for thiamine transporters 1 and 2 (ThTr1 and 324 
ThTr2) respectively (84-86). Genetic polymorphisms that compromise the 325 
integrity of ThTr1 and ThTr2 cause reduced active transport of thiamine across 326 
the enterocyte brush border and in the nephron, resulting in impaired thiamine 327 
absorption and increased renal loss. However, as passive absorption of thiamine 328 
also occurs, these defects have been successfully treated with thiamine 329 
supplementation (86).  330 
 Thiamine responsive megaloblastic anaemia (TRMA) occurs with ThTr1 331 
defect (84, 86) and thiamine metabolism dysfunction syndrome-2 occurs with 332 
THTR-2 defect (85). TRMA patients develop non-type I diabetes mellitus and 333 
treatment with thiamine has been reported to delay the onset of diabetes (86, 334 
87). 335 
 Similarly, defects of the genes that code for elements of the PDHC result in 336 
inborn errors of metabolism e.g. Leigh syndrome, which are also characterized 337 
by impaired glucose metabolism and increased lactic acid production (77, 88). 338 
Due to the reliance of the nervous system upon carbohydrate metabolism, these 339 
syndromes may manifest profound neurological symptoms, such as 340 
developmental delay and ataxia (84, 88).  341 
  These conditions vary in severity and responsiveness to thiamine therapy 342 
according to the degree of penetrance of the genetic defect (77, 86). While these 343 
genetic variants provide valuable insight into thiamine dependent metabolic 344 
processes, the overall incidence of these conditions is very rare. For example, 345 
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Patel et al reviewed the literature published between 1970-2010 and found a 346 
total of 371 cases of PDC deficiency (88). 347 
 348 
Thiamine and magnesium 349 
 The formation of TDP from thiamine requires magnesium, adenosine 350 
triphosphate (ATP) and the enzyme thiamine pyrophosphokinase (66). TDP 351 
dependent enzymes also require the presence of a divalent cation to achieve 352 
activation and magnesium has been demonstrated to provide optimal activation 353 
(89, 90). Although these aspects of the relationship between thiamine and 354 
magnesium have been well-understood biochemically for decades, the potential 355 
clinical relevance of such a relationship has received little attention to date (91, 356 
92). 357 
 It is of interest that a recent NHANES study would suggest that two thirds 358 
of North Americans may be magnesium deficient (20, 47, 93). The RDA for 359 
magnesium is 320mg and 420mg for women and men respectively (47). 360 
Dietary intake of magnesium may be subnormal by 65 – 220mg /day depending 361 
on geographic region (11, 93). Chronic ingestion of excessive amounts of sugar in 362 
the context of a micronutrient poor diet may, given the requirement for TDP and 363 
magnesium, results in altered metabolism (i.e. a dirty burn) (94). For example, 364 
obesity is also reported to be associated with magnesium deficiency (95-99). 365 
Intracellular magnesium also plays a key role in regulating insulin action, 366 
insulin-mediated-glucose-uptake and vascular tone (95, 98, 100, 101).  Several 367 
epidemiologic studies have shown that adults and children consuming a western 368 
 19 
type diet are consuming 30 – 50% of the RDA for magnesium (47, 93, 102). This 369 
deficiency appears to be predominantly subclinical and therefore not routinely 370 
investigated (11, 94, 103, 104).  371 
 Furthermore, the measurement of magnesium in the blood is 372 
problematical since it is recognized to be perturbed by the systemic 373 
inflammatory response (105), and measurable serum magnesium accounts for 374 
only 0.15% of total body magnesium. As a result, serum concentrations are likely 375 
to poorly reflect intracellular magnesium reserves (11, 103, 106). Finally, the 376 
accepted normal range was originally described among a population who may 377 
have been deficient (11, 106-109).  378 
It is therefore of interest that recent meta-analyses and cohort studies 379 
have pointed to an inverse relationship between magnesium consumption and 380 
the incidence of NIDDM / metabolic syndrome (95, 110-121) and that a recent 381 
prospective randomized controlled trial has demonstrated enhanced insulin 382 
sensitivity in a population of 128 obese patients with confirmed 383 
hypomagnesemia, chronic renal impairment and impaired glucose tolerance, in 384 
response to magnesium supplementation (365 mg per day for three months 385 
duration) (122). A similar study in a smaller sample size (n=72) of obese 386 
patients with metabolic syndrome, confirmed reduced baseline intracellular 387 
(monocyte) magnesium concentrations in 36% of obese patients but did not 388 
report any improvement in markers of insulin resistance in response to 389 
magnesium supplementation (400 mg per day for three months duration), 390 
however potential compliance issues and a small study sample render these 391 
results less reliable (123).  Navarette-Cortes et al also reported no change in 392 
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indices of glucose control from a small (n=56) cross-over double blind 393 
prospective randomized controlled trail of normomagnesemic NIDDM patients 394 
in response to magnesium supplementation (365 mg per day for three months 395 
duration) (124).  396 
Also, despite the limitations of the serum magnesium concentration, 397 
Bertinato et al have recently reported from an age stratified population based 398 
study of 5,446 participants, that up to 16% of the Canadian population had a 399 
serum magnesium concentration below the lower cut off of the population based 400 
reference range 0.75 – 0.95 mmol/L as defined by the NHANES group (109), and 401 
that serum magnesium concentration negatively correlated with diabetes and 402 
indices of insulin resistance and glycemic control (125).    403 
  Overall, when thiamine deficiency is considered with magnesium, it is 404 
likely that the deficiency of one or both may affect the other and compromise 405 
glucose metabolism in the obese patient.  406 
 407 
Compromised PDH activity and lactate production in obesity  408 
 Consistent with the above, it has been recognized for decades that lactate 409 
concentrations are chronically elevated in obese diabetic patients (126-129). 410 
Adipocytes are known to produce lactate and it is accepted that raised lactate 411 
precedes the onset of insulin resistance in obese patients (128, 130). In health, 412 
adipose tissue PDH activity is insulin responsive, while in vitro studies of PDH 413 
activity in adipocytes from obese and NIDDM patients have demonstrated a loss 414 
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of this responsiveness (131, 132). Thiamine deficiency compromises PDH 415 
activity (64), and therefore may mediate PDH resistance to insulin.  416 
 Compromised PDH activity results in a ‘dirty burn’ and the accumulation of 417 
lactate (73). Furthermore, lactate load is recognized to be proportionate to the 418 
mass of adipocytes (133), and the rate of lactate production has also been 419 
reported to be associated with the age of the adipocyte. Hence lactate production 420 
may be proportionate to the extent and duration of the obesity state (128). 421 
Chronically elevated lactate therefore heralds the onset of insulin resistance and 422 
NIDDM (134).  423 
 Clearly, in the context of the present review, this may reflect progressive 424 
exhaustion of intracellular thiamine and / or magnesium reserves due to a 425 
sustained high caloric burden. This simple hypothesis may be readily tested in 426 
the obese population by examination of the relationship between thiamine, 427 
magnesium and lactate.  428 
The implications of the above observations are several and profound, as 429 
subclinical thiamine and / or magnesium deficiency may render the individual 430 
more vulnerable to insulin resistance and oxidative stress in the acute or chronic 431 
disease state (135, 136).   432 
 With reference to chronic disease, it is recognized that an elevated BMI in 433 
the obese range is an established risk factor for diseases such as type 2 diabetes 434 
(T2DM), cardiovascular diseases, and many cancers (95, 137). Indeed, dietary 435 
intake of thiamine and magnesium and their circulating concentrations have 436 
been associated with lower risk of these conditions (95, 97, 114, 138-142). For 437 
example, Wu et al conducted a meta-analysis which indicates that circulating 438 
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magnesium levels are inversely associated with incidence of CHD, hypertension, 439 
and T2DM (114). Despite numerous reviews highlighting a potential role for 440 
magnesium in T2DM (95, 114, 138), no definitive study has been conducted to 441 
clarify the therapeutic potential of this widely available nutritional supplement 442 
in the treatment of T2DM and associated complications. Similarly, despite 443 
identification of widespread thiamine deficiency among patients with T2DM and 444 
promising pilot study data in relation to treatment of the metabolic 445 
complications of T2DM with thiamine (44, 142), the protective effect of thiamine 446 
supplementation remains unproven in a prospective randomised controlled trial 447 
setting.   448 
 Furthermore, the specific biological mechanism mediating the interface 449 
between obesity, thiamine, magnesium and these conditions is not yet clear and 450 
no study has examined the combined effect of thiamine and magnesium in this 451 
spectrum of chronic disease conditions. 452 
 453 
Conclusion  454 
 In summary, there is evidence that obesity may be associated with 455 
thiamine deficiency. This may be due to a mismatch between caloric burden and 456 
function of thiamine dependent enzymes. Thiamine, in turn, requires magnesium 457 
to be in its active form TDP. TDP also requires magnesium to achieve activation 458 
of TDP dependent enzymes during metabolism of glucose. Thiamine and 459 
magnesium play a critical role in glucose metabolism and their deficiency may 460 
result in the accumulation of anaerobic metabolites including lactate.  461 
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 It may therefore be postulated that thiamine and magnesium deficiency are 462 
under-recognized in obesity and may be important in the progress of obesity and 463 
obesity related chronic disease states. 464 
 465 
 466 
 467 
 468 
 469 
 470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
 478 
 479 
 480 
 481 
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Appendix 1. 482 
1. exp Bariatric Surgery/ 
 2. exp Obesity/ 
 3. (bariatric adj3 surg*).ti,ab. 
 4. obes*.ti,ab. 
 5. 1 or 2 or 3 or 4 
 6. exp Thiamine Deficiency/ or exp Thiamine Pyrophosphatase/ or exp     
Thiamine/ or exp Thiamine Pyrophosphate/ or exp Thiamine 
Monophosphate/ or exp Thiamine Triphosphate/ 
 7. (thiamine or thiamin or vitamin B1).ti,ab. 
 8. 6 or 7 
 9. exp Magnesium/ or exp Magnesium Deficiency/ 
10. magnesium.ti,ab. 
11. 9 or 10 
12. 5 and (8 or 11) 
13. exp Diabetes Mellitus, Type 2/ 
14. type 2 diabetes.ti,ab. 
15. 13 or 14 
16. non insulin dependent diabetes.mp. 
17. non insulin dependent diabetes.ti,ab. 
18. 16 or 17 
19. metabolic syndrome.mp. 
20. metabolic syndrome.ti,ab. 
21. 19 or 20 
22. 15 or 18 or 21 
23. 22 and (8 or 11) 
24. (5 or 22) and (8 or 11) 
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Appendix 2 491 
 492 
 493 
Search sieve for literature search detailed in appendix 1 including hand searched 494 
references 495 
 496 
 497 
 498 
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Appendix 3 499 
 500 
Table 1. Summary of thiamine values presented in Bariatric Surgery papers 501 
Thiamine conversion: 1ug = 3 nmol 502 
 503 
 504 
 505 
 506 
 507 
 508 
 509 
 510 
 511 
Author normal male female  ‘Lowest 
value’ 
Carrodeguas (ug/dl) 
(37) 
3.8 - 12.2  2.8-3.6 ug/dl 1.2 - 3.6 ug/dl  
Carrodeguas (nmol/l) 
(37)  
114 – 366 84 – 108 
nmol/l. 
36 – 108 
nmol/l. 
 
Flancbaum (ug/dl) 
(38) 
- - - 10.86 ug/dl. 
Mayo clinic 70 - 180 
nmol/l. 
2.66 – 6 ug/dl 
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